LETTER TO PRESCRIBING PROVIDERS
September
17, 2004
Dear Prescribing
Practitioner:
Attached is the
complete, most current listing of drugs on the Medicaid Prior Authorization (PA)
Process' Preferred Drug List (PDL) "04-03." The listing includes preferred drugs and those drugs requiring prior
authorization. This
list will be effective October 1, 2004.
The
PA process, in accordance with the program's "Continuity of Care" policy,
does not impact original prescriptions (or refills) issued by a prescribing
practitioner prior to effective PA dates of drugs as they are added to the PA
process as
long as they are within the 5 refills and 6-month program limits. An
educational alert will notify the pharmacist that prescriptions (and their
refills) will require a new prescription and prior authorization, if the
prescription life exceeds six months or the refill exceeds the 5 refill limit.
The educational alert will state, "NEW RX WILL REQUIRE PA AFTER (DATE)."
Information on
the Prior Authorization process, including the PDL and Prior Authorization
Request Form (copy is attached, Form RXPA01), is also available on the Louisiana
Medicaid website (www.lamedicaid.com).
This website will be updated when changes (additions or deletions) are made to
the PDL. The program may also utilize the provider remittance advices to notify
providers of PDL changes that must be implemented in short time frames.
The Department has received inquiries that drug products
requiring PA are not reimbursable by Medicaid. Medicaid does reimburse for drug
products requiring prior authorization when the prior authorization process is
followed.
Also,
attached is Appendix D detailing the information required to review retroactive
eligibility. Please be advised that
pharmacy claims will only be overridden for the prior authorization edit for eligibles with
certified retroactive eligibility. Claims submitted for eligibles who do not have retroactive eligibility
will not have the PA edit overridden.
Thank
you for your continued cooperation. We appreciate your participation in the
Medicaid Program.
Sincerely,
Ben
A. Bearden
Medicaid Director
BAB/ht
Attachments (3)
The above letter and the Preferred Drug
List are
also available in PDF format on the Downloadable
Forms and Files page.